Sensulin

This company develops glucose-responsive insulin that automatically adjusts to blood sugar levels, eliminating the need for multiple daily injections. Their insulin aims to simplify diabetes management by combining basal and prandial insulin delivery into a single formulation, reducing the burden of frequent glucose monitoring.

Traction 4/10

Oklahoma City, United States · HQ

Founded 20118200+ followers

Biotechnology

Updated 19 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

1 founder

Daniel Bradbury

Managing Member

Product

Features

This company develops glucose-responsive insulin that automatically adjusts to blood sugar levels, eliminating the need for multiple daily injections. Their insulin aims to simplify diabetes management by combining basal and prandial insulin delivery into a single formulation, reducing the burden of frequent glucose monitoring.